evodiamine has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lou, Y; Ren, L; Sun, M | 1 |
| Chen, J; Sun, Y; Wang, J; Wu, Y; Zhang, Y; Zhao, J | 1 |
| Feng, H; Guo, B; Kong, X; Wu, B | 1 |
3 other study(ies) available for evodiamine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Glycation End Products, Advanced; Humans; Mice; Mice, Nude; Mouth Neoplasms; Quinazolines; Receptor for Advanced Glycation End Products; Signal Transduction | 2021 |
Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Oligonucleotide Array Sequence Analysis; Quinazolines; Tongue Neoplasms | 2019 |
[Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells].
Topics: Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA-Activated Protein Kinase; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Humans; Ku Autoantigen; Nuclear Proteins; Plant Extracts; Quinazolines; Rad51 Recombinase; Radiation Tolerance; X-Rays | 2016 |